Henry Rath, MBA

Henry Rath, MBA
Chief Business Officer

Henry serves as the chief business officer at Surface Oncology, responsible for business development, program and alliance management and portfolio strategy functions. He has over 25 years of experience in the biotechnology industry with roles spanning corporate finance, strategy, commercial planning, and business development. Prior to joining Surface, Henry worked at TScan Therapeutics, Seres Therapeutics, Amgen, Catabasis, and Baxter Biopharmaceuticals, and completed in- and out-licensing transactions as well as mergers and acquisitions in the United States and internationally. He began his career with roles in the banking and consulting industries focusing on biotechnology with Oppenheimer & Co. and LEK Consulting. Henry earned his undergraduate degree from Harvard College and his M.B.A. from the Wharton School of the University of Pennsylvania.